11th Swiss Pharma Science Day 2018 – „Cancer“

This year’s Swiss Pharma Science Day is focused on Cancer with the following presentations:


«National Strategy Against Cancer»

Dr. sc.nat. Michael Röthlisberger,  Nationale Strategie gegen Krebs, Krebsliga, Bern


«Non-biological Complex Nanomedicines and Their Preclinical Evaluation»

Dr. Scott McNeil, NCL-NCI Frederick MD, U.S.A.


«Lessons to be Learned: The Molecular Basis of Kinase-Targeted Therapies and Drug Resistance in Non-Small Cell Lung Cancer»

Prof. Dr. Daniel Rauh, TU Dortmund


«Development of Oral LFA-1 Inhibitors»

Prof. Dr. pharm. et med. Stephan Krähenbühl, University Hospital & University of Basel


«Nonadherence to Oral Targeted Anticancer Drugs: What’s the Problem and How to Address It ?»

Dr. Marie-Paule Schneider, Policlinique MédicaleUniversitaire and EPGL University of Geneva


More Information & Registration & Poster Session


If you like to Sponsor the Event, please get in touch via Email to [email protected]


11th Swiss Pharma Science Day – Program
sphsd 2018_program_final.pdf
Adobe Acrobat Document 332.2 KB

11th Swiss Pharma Science Day- Poster Information
sphsd 2018_poster.pdf
Adobe Acrobat Document 39.7 KB

You might also like